E Fund Management’s Altimmune ALT Stock Holding History

E Fund Management’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$89.5K	Buy	+29,072	New	+$123K	﹤0.01%	474
2025 Q2	$44K	Sell	11,357 -2,070	-15%	-$11.2K	﹤0.01%	391
2025 Q1	$67.1K	Buy	13,427 +2,268	+20%	+$14.4K	﹤0.01%	391
2024 Q4	$80.5K	Buy	11,159 +1,149	+11%	+$8.78K	﹤0.01%	383
2024 Q3	$61.5K	Sell	10,010 -3,448	-26%	-$23.4K	﹤0.01%	348
2024 Q2	$89.5K	Sell	13,458 -28,251	-68%	-$208K	﹤0.01%	307
2024 Q1	$425K	Buy	+41,709	New	+$424K	0.03%	193
2023 Q2	–	Sell	-29,334	Closed	-$124K	–	311
2023 Q1	$124K	Sell	29,334 -1,952	-6%	-$23.2K	0.01%	317
2022 Q4	$515K	Buy	31,286 +10,646	+52%	+$120K	0.04%	128
2022 Q3	$264K	Buy	+20,640	New	+$305K	0.02%	255
2022 Q1	–	Sell	-11,936	Closed	-$109K	–	327
2021 Q4	$109K	Buy	+11,936	New	+$127K	﹤0.01%	286

Other funds holding ALT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

E Fund Management's ALT Position: Q1 2026 in Review

E Fund Management opened a new position in Altimmune (ALT) in Q1 2026: 29,072 shares worth $89.5K. The stake represents ﹤0.01% of the portfolio and ranks #474 among its holdings. This is a return to the name: E Fund Management previously reported a position in ALT as recently as Q2 2025.

E Fund Management first reported a position in ALT in Q4 2021 and has held it in 11 quarters since. The position peaked at $515K in Q4 2022. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

E Fund Management held 29,072 shares of Altimmune worth $89.5K as of Q1 2026.
Altimmune was a new E Fund Management position in Q1 2026.
Altimmune made up ﹤0.01% of E Fund Management's portfolio in Q1 2026, its #474 holding.
E Fund Management first reported a position in Altimmune in Q4 2021 and has held it in 11 quarters since.
E Fund Management's Altimmune position peaked at $515K in Q4 2022.
173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on E Fund Management's 13F filing for Q1 2026, filed 13 Apr 2026.